Survival of homologous recombination InR alleles. Females. Plots represent independent trials except for repeated controls shown in (B and E), and in (C, F, and G). In all trials, wild-type and null allele controls were homologous recombinant InR+(HR) and InRnull(HR) respectively. (A) Wild-type heterozygotes made with three accessions of ectodomain mutant InRE19(HR). (B) Wild-type heterozygotes made with mutants of the kinase domain A-loop (InR74(HR)) and C-terminal lobe (InR211(HR)). (C) Wild-type heterozygotes made with mutants of kinase domain N-terminal lobe (InR246(HR)), A-loop, KID (InR353(HR)), and C-terminal lobe; hemizygotes shown for contrast. (D) Wild-type heterozygotes made with three accessions of the kinase insert domain mutant InR353(HR). (E) Transheterozygotes of InRE19(HR), InR74(HR), and InR211(HR). (F) Independent, replicate trails of transheterozygotes of InRE19(HR), InR74(HR), and InR211(HR). (G) Transheterozygotes of InRE19(HR), InR74(HR), InR246(HR) and InR353(HR). (H) Independent, replicate trail of transheterozygotes of InRE19(HR), InR74(HR), InR246(HR), and InR353(HR). Life table summaries and proportional hazard statistics in Supplementary Table S4.